Colorado Prevention Center Adopts Electronic Data Capture and Chooses OmniComm Systems, Inc. as Its Premier Vendor

FT. LAUDERDALE, FL, Aug 05 (MARKET WIRE) --
OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic
data capture (EDC) solutions for clinical trials, today announced that
Colorado Prevention Center (CPC) has chosen OmniComm as their preferred
provider as they move from paper data collection to EDC for their
clinical trials. CPC delivers all of the traditional services of a CRO
with additional emphasis on the quality of the science and trial
conduction. Joining the CRO Preferred Program allows them to offer
superior electronic data capture services and support to their clinical
development clients worldwide.

"We conducted an exhaustive search of EDC vendors that drilled down to 30
high level candidates. Ten (10) of those companies were issued a request
for proposal and only 4 leading companies were chosen to provide
demonstrations of their products and services. OmniComm exceeded our
expectations with the best services and software by far and was the clear
winner in the evaluation," said Evan King, COO of Colorado Prevention
Center. "We are very excited to have made the move to EDC and we look
forward to working in tandem with the team at OmniComm."

CPC (www.cpcmed.org) is dedicated to improving health through clinical
research and integrating scientific evidence into community prevention
programs. CPC supports every aspect of clinical research, including study
design, comprehensive trial management and completion of final study
reports. In addition to these traditional services, CPC provides a unique
quality intervention program that improves the ability to detect treatment
effect. CPC also provides unmatched scientific leadership and publications
of academic hypotheses arising from industry and non-industry research.

"When companies like CPC join our CRO Preferred Program, they gain an EDC
partner that shares their dedication to delivering excellence," said
Stephen Johnson, COO of OmniComm. "In this highly competitive marketplace,
CROs need to know that they have a real partner that they can trust to
provide the same high caliber deliverables that their clients have come to
expect. Working with OmniComm ensures that level of security for our
partners that choose to use TrialMaster(TM) for EDC."

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven
Internet solutions to pharmaceutical, biotechnology, research and medical
device organizations that conduct life changing clinical trial research.
OmniComm's growing base of satisfied customers is a direct result of the
company's commitment to deliver products and services that ensure ease of
use, faster study build, ease of integration and better performance.
OmniComm's client intuitive pricing model allows companies that range from
small to mid-size to large scale institutions to safely and efficiently
capitalize on their clinical research investments. OmniComm Systems, Inc.
has corporate headquarters in Ft. Lauderdale, Florida with offices in
Bonn, Germany, Tula, Russia, California, Maryland, New York, North
Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without
limitation, future revenues and earnings, plans and objectives for the
future operations, future agreements, future economic performance,
operations and all other statements in this press release other than
historical facts are "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Securities Litigation Reform Act of 1995. OmniComm intends that such
forward-looking statements be subject to the Safe Harbors created
thereby. Since these statements involve risks and uncertainties,
including but not limited to economic competitive, governmental,
contractual and technological factors affecting OmniComm's operations,
markets and profitability, actual results could differ materially and
adversely from the expected results.

CONTACT:
Lizanne Kelley
OmniComm Systems, Inc.
954-473-1254 Extension 283
Email Contact

Evan King
CPC
789 Sherman St., Suite 200
Denver, CO 80203
303.860.9900
Email Contact

Copyright 2008, Market Wire, All rights reserved.

-0-